Centro de Ingeniería Genética y Biotecnología-ko ikertzaileekin lankidetzan egindako argitalpenak (27)

2020

  1. Heterologous prime-boost strategy based on the combination of a tetravalent vaccine of recombinant proteins and live-attenuated virus as a promising vaccine strategy against dengue virus

    Biotecnologia Aplicada, Vol. 37, Núm. 1, pp. 1501-1504

2017

  1. A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C

    Human Vaccines and Immunotherapeutics, Vol. 13, Núm. 11, pp. 2548-2560

2014

  1. Characterization of the vegetal growth promoting capacity of Tsukamurella paurometabola C-924 and the main mechanisms involved

    Biotecnologia Aplicada, Vol. 31, Núm. 2, pp. 168-171

2013

  1. Biological activity in vitro and in vivo of an in silico designed secretagogue peptide to be used in fish

    Biotecnologia Aplicada, Vol. 30, Núm. 4, pp. 320-322

2011

  1. Protective immune response against Neisseria meningitidis serogroup B after immunization with peptides mimicking a capsular polysaccharide epitope

    Biotecnologia Aplicada, Vol. 28, Núm. 2, pp. 113-115

2009

  1. Analysis of the genetic variability and immunological properties of the NlpB antigen, a novel protein identified in Neisseria meningitidis

    Biotecnologia Aplicada, Vol. 26, Núm. 1, pp. 84-87

  2. Assessment of vaccine potential of the Neisseria-specific protein NMB0938

    Vaccine, Vol. 27, Núm. 49, pp. 6910-6917

2008

  1. Inmunlzaclón con fragmentos de ADN para el estudio de la respuesta contra antígenos de Neisseria meningitidis

    Biotecnologia Aplicada, Vol. 25, Núm. 2, pp. 183-190

2007

  1. A novel method to screen genomic libraries that combines genomic immunization with the prime-boost strategy

    FEMS Immunology and Medical Microbiology, Vol. 50, Núm. 3, pp. 430-433

  2. Caracterización de proteínas presentes en proteoliposoma de N. meningitidis. Estudios de consistencia y reproducibilidad entre lotes de VA-MENGOC-BC® mediante técnicas proteómicas

    Biotecnologia Aplicada, Vol. 24, Núm. 2, pp. 164-171

  3. Clinical management and prevention of septicaemia and meningitis in children and adults: An update

    Biotecnologia Aplicada, Vol. 24, Núm. 3-4, pp. 298-302

  4. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate

    Vaccine, Vol. 25, Núm. 50, pp. 8420-8431

2006

  1. Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera

    Journal of Microbiological Methods, Vol. 65, Núm. 1, pp. 135-143

  2. Immunization with Neisseria meningitidis outer membrane vesicles prevents bacteremia in neonatal mice

    Vaccine, Vol. 24, Núm. 10, pp. 1633-1643

2005

  1. Memory immune response generated in Cercopithecusaethiops against meningococcal polysaccharide serogroup C conjugate vaccine

    FEMS Immunology and Medical Microbiology, Vol. 43, Núm. 2, pp. 133-140

2004

  1. Association of the P64k dihydrolipoamide dehydrogenase to the Neisseria meningitidis membrane

    Biotecnologia Aplicada, Vol. 21, Núm. 3, pp. 137-142

  2. Cell mediated immune response elicited in mice after immunization with the P64k meningococcal protein: Epitope mapping

    FEMS Immunology and Medical Microbiology, Vol. 42, Núm. 2, pp. 233-239

  3. Effect of conjugation methodology on the immunogenicity and protective efficacy of meningococcal group C polysaccharide-P64k protein conjugates

    FEMS Immunology and Medical Microbiology, Vol. 40, Núm. 3, pp. 193-199

2003

  1. Aportes a la caracterización molecular e inmunológica de porinas de bacterias Gram-negativas y sus regiones variables

    Biotecnologia Aplicada, Vol. 20, Núm. 1, pp. 52-55

2001

  1. Effect of p64k presensitization on its efficacy as an immunological carrier in mice

    Biochemical and Biophysical Research Communications, Vol. 282, Núm. 2, pp. 376-379